Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Director Dealing

12 Dec 2017 16:00

RNS Number : 1344Z
Thruvision Group PLC
12 December 2017
 

12 December 2017

Thruvision Group plc 

 

Director Dealing

Thruvision Group plc (AIM: THRU), ("Thruvision" the "Company" or, together with its subsidiary undertakings, the "Group") the specialist provider of people-screening technology to the global security market, announces that on 11 December 2017, Colin Evans, Managing Director of Thruvision, notified the Board of dealings in ordinary shares in the Company.

On 11 July 2017 Colin Evans' investment manager, HSBC, sold in error without his consent or knowledge;

 

· 108,398 ordinary shares in the Company (held in an ISA in the name of Colin Evans) at a price of 27.5 pence per share, a total of £29,808.95.

 

· 106,968 ordinary shares in the Company (held in an ISA in the name of his wife, Fiona Evans) at a price of 27.5 pence per share, a total of £29,415.70.

 

Following these transactions, Colin Evan's aggregated beneficial total shareholding in the company is 1,359,554 Ordinary Shares representing 0.82% of the Company's current total issued share capital and total voting rights.

 

Colin Evans was notified by HSBC of these transactions on Monday 11 December 2017 and informed the Company immediately. The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Colin Evans

2.

Reason for the notification

(a)

Position/status

Managing Director

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Thruvision Group plc

(b)

LEI

213800IZG9GM6G2TZE04

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.01 each

(b)

Identification code of the Financial Instrument

GB00B627R876

(c)

Nature of the transaction

Sale of shares

 

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

27.5p

215,366

(e)

Aggregated information

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

11 July 2017

(g)

Place of the transaction

London Stock Exchange

 

 

 

For further information please contact:

 

Thruvision Group plc

Tom Black, Executive Chairman

Colin Evans, Managing Director

 

+44 (0)20 3553 5888

Investec Bank plc (Financial Adviser, NOMAD & Broker)

Andrew Pinder / Sebastian Lawrence / Patrick Robb

 

+44 (0)20 7597 5970

FTI Consulting LLP

Edward Bridges / Matt Dixon / Harry Staight

 

+44 (0)20 3727 1000

 

 

About Thruvision

Thruvision Group plc is a specialist provider of people-screening technology that can safely see weapons, explosives and contraband hidden in peoples' clothing. Developed with extensive support from the British and US Governments, Thruvision technology is operationally proven and is being used to enhance the security of transport hubs, borders, high profile buildings and public areas.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBUBDDRUBBGRD
Date   Source Headline
4th Apr 20227:00 amRNSYear End Trading Update and Board Changes
1st Apr 20227:01 amRNSBlocklisting update
1st Apr 20227:00 amRNSBlocklisting update
9th Mar 202212:40 pmRNSDirector Share Dealing
21st Feb 20222:07 pmRNSExercise of Sharesave Share Options
25th Jan 20224:06 pmRNSSharesave option grant to Executive Director
24th Dec 20217:00 amRNSDirector Share Dealing
22nd Dec 202112:42 pmRNSHolding(s) in Company
2nd Dec 20216:00 pmRNSDirector Share Dealing
2nd Dec 20212:00 pmRNSInvestor Presentation
1st Dec 202111:36 amRNSDirector Share Dealing
30th Nov 20215:39 pmRNSAward of Share Options to Executive Directors
30th Nov 20211:50 pmRNSDirector Share Dealing
22nd Nov 20217:00 amRNSInterim Results
11th Nov 20217:00 amRNSNotice of Interim Results
27th Oct 20218:52 amRNSBlocklisting application
7th Oct 20217:00 amRNSTrading Update
4th Oct 20219:10 amRNSBlocklisting update
28th Sep 202110:31 amRNSResult of Annual General Meeting
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDirector Share Dealing
27th Jul 20211:00 pmRNSDirector/PDMR Shareholding
16th Jul 20213:27 pmRNSReplacement: Holding(s) in Company
15th Jul 20214:43 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSResults for the Year ended 31 March 2021
9th Jul 20212:34 pmRNSReplacement: Investor Presentation
9th Jul 202111:00 amRNSInvestor Presentation
5th Jul 202112:00 pmRNSNotice of Results
27th May 20211:24 pmRNSDirector Share Dealing
1st Apr 20217:00 amRNSPre-Close Statement
31st Mar 20213:00 pmRNSBlocklisting update
11th Mar 20215:53 pmRNSHolding(s) in Company
10th Mar 20213:33 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSAppointment of Non-Executive Director
1st Dec 20207:00 amRNSThruvision Investor Presentation
23rd Nov 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSNotice of Interim Results
9th Oct 202010:18 amRNSHolding(s) in Company
7th Oct 20207:00 amRNSPre-close Trading Update
22nd Sep 202010:31 amRNSResult of Annual General Meeting
18th Sep 20207:00 amRNSContract award announcement
26th Jun 202010:32 amRNSHolding(s) in Company
23rd Jun 20205:21 pmRNSHolding(s) in Company
22nd Jun 20204:24 pmRNSHolding(s) in Company
17th Jun 202011:05 amRNSSecond Price Monitoring Extn
17th Jun 202011:01 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSAward of Share Options to Executive Directors
8th Jun 20207:00 amRNSResults for the Year ended 31 March 2020
3rd Jun 20207:22 amRNSNotice of Annual Results
3rd Jun 20207:00 amRNSNotice of Annual Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.